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Objective. Monocyte recruitment by proinflam-
matory cytokines is a hallmark of rheumatoid arthritis
(RA). Lewisy-6 and H (Ley/H) are blood group antigens
up-regulated on RA synovial endothelium. We have
previously shown that both soluble Ley/H and a glucose
analog of H, H-2g, are angiogenic and mediate
leukocyte–endothelial adhesion via induction of inter-
cellular adhesion molecule 1. We hypothesized that
soluble Ley/H plays an important role in monocyte
recruitment in RA.
Methods. We examined the role of H-2g in mono-
cyte chemotaxis in vitro. We used an RA synovial tissue
(ST)–SCID mouse chimera model to evaluate the role of
H-2g in monocyte recruitment in vivo. We used Western
blots to examine signaling molecules activated by H-2g
in monocytes.
Results. H-2g induced human monocyte migra-
tion in vitro, which was mediated by Src and phospha-
tidylinositol 3-kinase (PI 3-kinase), since inhibitors and
antisense oligodeoxynucleotides (ODNs) of Src and PI
3-kinase significantly decreased H-2g–induced mono-
cyte migration (P < 0.05). H-2g significantly increased
mononuclear cell (MNC) homing in vivo into an RA
ST–SCID mouse chimera (P < 0.05). Transfection of
MNCs with Src antisense ODNs blocked H-2g–induced
MNC recruitment into the RA ST–SCID mouse chi-
mera. Additionally, H-2g induced marked phosphoryla-
tion of protein kinase CI/II (PKCI/II), Src, IB,
and Akt in monocytes. Src, Akt, and NF-B were shown
to be downstream targets of PKCI/II, since an inhib-
itor of PKCI/II reduced H-2g–mediated phosphory-
lation of Src, Akt, and NF-B in monocytes.
Conclusion. These data suggest that H-2g may be
a novel mediator of monocyte recruitment in chronic
inflammatory diseases like RA.
Leukocyte adhesion and recruitment are critical
steps in the pathogenesis of rheumatoid arthritis (RA)
(1,2). We have developed a monoclonal antibody
(mAb), termed 4A11, which detects the glycoconjugates
H-5-2 and Lewisy-6 (Ley/H). Ley/H is cytokine inducible
on human endothelial cells (ECs) (3). Soluble Ley/H
and a glucose analog of blood group H antigen,
2-fucosyllactose, termed H-2g, mediate angiogenesis and
leukocyte–endothelial adhesion via up-regulating endo-
thelial intercellular adhesion molecule 1 (ICAM-1) (3–
5). Activities of Ley/H are mimicked by H-2g, and H-2g–
induced angiogenesis is abrogated by mAb 4A11 (4).
Glycoconjugates play an important role in cell
adhesion and leukocyte trafficking at sites of inflamma-
tion as well as in angiogenesis (6). Nguyen et al have
identified a role for sialyl Lex in capillary morphogenesis
(7). Maly et al found that mice deficient in the enzymes
that generate sialyl Lex have a partial defect in neutro-
phil accumulation in response to an acute inflammatory
stimulus (8).
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In the present study, we examined the role of
H-2g in leukocyte ingress at sites of chronic inflamma-
tion. We determined the signaling mechanisms by which
H-2g recruits monocytes in vitro and in vivo. We evalu-
ated its role in leukocyte migration in an RA synovial
tissue (ST)–SCID mouse chimera. H-2g induced phos-
phorylation of protein kinase CI/II (PKCI/II), Akt,
and NF-B in monocytes. Our data suggest that thera-
pies targeting H-2g, such as mAb 4A11, may be benefi-
cial in treating chronic inflammatory diseases such as
RA.
MATERIALS AND METHODS
Isolation of human monocytes and chemotaxis in vitro.
Monocytes were isolated from normal human peripheral blood
(PB) as described previously (9–11). Cell viability determined
by trypan blue exclusion was 98%, and purity was 80%.
Monocyte chemotaxis was performed using 48-well modified
Boyden chambers (Neuro Probe, Cabin John, MD) as de-
scribed elsewhere (10,11). Hanks’ balanced salt solution
(HBSS) and fMLP (100 nM) served as negative and positive
controls, respectively.
We performed monocyte chemotaxis in vitro to inves-
tigate the signaling mechanisms involved in H-2g–induced
monocyte migration using the chemical signaling inhibitors
PP2 529573 (Src inhibitor), LY294002 (phosphatidylinositol
3-kinase [PI 3-kinase] inhibitor), and pertussis toxin (G protein
inhibitor). All inhibitors were purchased from Calbiochem
(San Diego, CA) except for pertussis toxin, which was pur-
chased from Sigma (St. Louis, MO). Inhibitors were used at 10
M concentration except for pertussis toxin, which was used at
500 ng/ml. Concentrations of fMLP and signaling inhibitors
were based on optimal concentrations used previously, and the
chemical signaling inhibitors are not toxic at the concentration
used in this study (4,9,11,12). Monocyte chemotaxis assays
were performed with H-2g and fMLP with and without in-
hibitors as described (10,11). To confirm our results, mono-
cytes were transfected with Src and PI 3-kinase sense and anti-
sense oligodeoxynucleotides (ODNs) for 48–72 hours, and
chemotaxis was performed. ODN sequences of signaling
intermediates used were as follows: for PI 3-kinase, sense
ATGAGTGCTGAGGGGTACCAGTAC and antisense GT-
ACTGGTACCCCTCAGCACTCAT; for Src, sense ATGGG-
GAGCAGCAAGAGCAAGCCC and antisense GGGCTTG-
CTCTTGCTGCTCCCCAT.
Mononuclear cell (MNC) homing in human RA
ST–SCID mouse chimeras. Human ST was obtained from RA
patients undergoing joint replacement. SCID mice (ages 4–6
weeks) were purchased from the National Cancer Institute.
Anesthetized mice received 1 RA ST graft (0.7  0.7  0.5
cm) in the back, and the wound was sutured.
After 4 weeks of engraftment, isolated human PB
MNCs were dye-tagged with fluorescent PKH26 (Sigma)
(10,12). Each mouse was injected intravenously with dye-
tagged MNCs (5  106). Simultaneously, we administered
an intragraft injection of H-2g (10 M). Mice were eutha-
nized after 48 hours and grafts were removed. Cryosections
(8–10-m thick) were examined for cell homing under fluo-
rescence. Migrated labeled MNCs were quantified in grafts by
counting the total number of cells in 24 tissue sections per
group of mice. The number of high-power fields (hpf) counted
was dependent upon the size and composition of the graft and
corresponding tissue section, counting all the labeled cells in
the entire tissue section. Approximately 30–60 hpf were
counted per tissue section obtained from each transplant. Phos-
phate buffered saline (PBS) served as a negative control. The
experimental controls were the same as those used in a previously
reported study testing the effects of H-2g and CXCL16 in MNC
recruitment in ST-SCID mouse chimeras (10).
Monocytes were transfected with fluorescein isothio-
cyanate (FITC)–labeled ODNs to NF-B for 24 hours to
determine the transfection efficiency with lipofectin (Invitro-
gen, Carlsbad, CA). To evaluate the role of signaling interme-
diates in H-2g–induced MNC recruitment in vivo, MNCs were
transfected with Src sense or antisense ODNs for 72 hours
using lipofectin (9,10). The RA ST–SCID mouse chimera
model was used with transfected MNCs, as described above
(10,12). ST grafts were harvested after 48 hours, and cryosec-
tions were analyzed for migrated fluorescent MNCs.
Cell lysis and immunoblotting. Cell lysis and immuno-
blotting were performed as described previously (4,11). Mono-
cytes were stimulated with H-2g (200 nM) for various time
periods. To determine the role of signaling inhibitors, monocytes
were preincubated with chemical inhibitors for 1 hour before
stimulating with H-2g for 15 minutes. Monocytes transfected with
PKC or Src sense or antisense ODNs were stimulated with H-2g
for 15 minutes. Western blotting was then performed, and blots
were probed with phosphospecific antibodies (Cell Signaling
Technology, Beverly, MA). Blots were stripped and reprobed for
total PKC, Src, Akt, and IB to verify equal loading. The ODN
sequences of PKC used were TCGGGGGGGACCATG
(sense) and CATGGTCCCCCCCGA (antisense). After transfec-
tion, monocytes were stimulated with H-2g (200 nM) for 15
minutes, and cell lysates were collected. To determine transfec-
tion stability, we transiently transfected monocytes with Src sense
and antisense ODNs for 24, 48, and 72 hours and stimulated
monocytes with H-2g for 15 minutes.
Statistical analysis. Student’s t-tests were performed,
and P values less than 0.05 were considered significant. Data
represent the mean  SEM of 3 experiments.
RESULTS
H-2g induces monocyte chemotaxis in vitro. H-2g
induced monocyte migration in the picomolar range in a
dose-dependent manner, showing significance at 100 pM
(P  0.05), suggesting that H-2g was potently chemotac-
tic for human monocytes (Figure 1A). H-2g increased
migration of monocytes 2.3-fold at 100 pM and 4.5-fold
at 100 M compared with HBSS (P  0.05).
Src and PI 3-kinase mediate H-2g–induced
monocyte migration in vitro. H-2g–induced monocyte
migration was mediated by Src and PI 3-kinase, while G
proteins were not involved, suggesting that Src and PI
3-kinase play an important role in H-2g–mediated
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monocyte chemotaxis (Figure 1B). Signaling inhibitors
of Src (PP2 529573) and PI 3-kinase (LY294002) signif-
icantly decreased H-2g–induced monocyte migration,
but an inhibitor of G protein (pertussis toxin) did not
(P  0.05).
Src mediates fMLP-induced monocyte chemo-
taxis in vitro. In contrast to results obtained with H-2g,
while Src plays an important role in fMLP-induced
monocyte migration, since an inhibitor of Src (PP2
529573) inhibited fMLP-induced monocyte chemotaxis,
Figure 1. A, Induction of monocyte chemotaxis in vitro by H-2g. H-2g induced a concentration-dependent increase in human monocyte chemotaxis
when monocytes were incubated with H-2g for 1.5 hours. H-2g–induced monocyte migration was greater than that exhibited by the positive control,
fMLP (100 nM). Data represent the mean and SEM of 3 individual experiments. Each experiment was repeated at least 3 times, and there were 4
replicate wells in each experimental group. Three high-power fields (hpf) at 400 magnification were counted in each replicate well, and results are
expressed as monocytes/3 hpfs.   P  0.05 versus Hanks’ balanced salt solution (HBSS). B, H-2g–induced monocyte migration inhibited by
inhibitors of phosphatidylinositol 3-kinase (PI 3-kinase [PI3K]) (LY294002) and Src (PP2 529573). Monocytes were incubated with signaling
inhibitors (10 M) for 15 minutes, and in vitro chemotaxis was performed with H-2g. Data represent the mean and SEM of 3 individual
experiments. HBSS served as a negative control. All inhibitors were present during the experiment. n  number of experiments using cells from
different donors.   P  0.05. C, Critical role of Src in fMLP-induced monocyte migration. To contrast the signaling events of the potent monocyte
chemoattractant fMLP with those of H-2g, we performed monocyte chemotaxis with fMLP in the presence and absence of various signaling
inhibitors. Monocyte migration induced by fMLP was inhibited by a Src inhibitor (  P  0.05), but inhibitors of PI 3-kinase and MEK-1/2 (MAPK)
did not have a role in fMLP-induced monocyte migration. Signaling inhibitors also did not affect HBSS-induced monocyte basal migration. n 
number of experiments using cells from different donors. D, Essential roles of Src and PI 3-kinase in H-2g–induced monocyte chemotaxis in vitro.
To confirm our results, monocytes were transfected with Src and PI 3-kinase sense (S) and antisense (AS) oligodeoxynucleotides (ODNs) for 48–72
hours. H-2g–induced monocyte chemotaxis was significantly decreased in monocytes transfected with Src or PI 3-kinase antisense ODNs compared
with sense ODN–transfected monocytes. Data represent the mean and SEM of 3 individual experiments. n  number of experiments using cells
from different donors.   P  0.05.
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inhibitors of PI 3-kinase and MEK-1/2 did not decrease
the chemotaxis. None of the inhibitors decreased mono-
cyte migration in response to negative control HBSS
(Figure 1C).
Src and PI 3-kinase antisense ODNs inhibit
H-2g–induced monocyte chemotaxis in vitro. To con-
firm the data obtained with chemical signaling inhibi-
tors, we transfected monocytes with sense or antisense
ODNs of Src and PI 3-kinase. Initially, to determine
transfection efficiency, we transfected monocytes with
FITC-bound ODNs to NF-B and found the transfec-
tion efficiency to be 80% (Figure 2B). MNC viability
was 80–85% after transfection with Src or PKC ODNs
for 72 hours, as determined by MTT assay (data not
shown), consistent with viability after transfection of
monocytes with other (ERK-1/2) ODNs (10). H-2g–
induced monocyte migration was significantly decreased
by antisense ODNs of Src and PI 3-kinase compared
Figure 2. A, Recruitment of mononuclear cells (MNCs) by H-2g in a human rheumatoid arthritis (RA) synovial tissue (ST)–SCID mouse chimera.
After 4 weeks of human RA ST engraftment in SCID mice, dye-tagged MNCs (5  106) were injected intravenously (IV) into each mouse. At the
same time, ST grafts were injected with H-2g (10 M/graft) or phosphate buffered saline (PBS), and grafts were harvested after 48 hours. The
number of fluorescence-labeled cells was significantly higher in the grafts injected with H-2g than in those injected with PBS. The upper panel shows
a representative RA ST section with dye-tagged MNCs migrated to the graft in response to H-2g, while grafts sham injected with PBS show limited
MNC migration (original magnification  100). Twenty-four tissue sections were counted per test group of animals. For the PBS group, 6 tissue
sections were counted for each of 4 mice, using the same negative control group we have used previously (10). For the H-2g group, 8 tissue sections
were counted for each of 3 mice. Results are expressed as the mean and SEM cells/hpf using data obtained from 24 tissue sections analyzed in each
test group.   P  0.05. B, Transfection of human monocytes with fluorescein isothiocyanate (FITC)–labeled ODNs to NF-B. Human monocytes
were transfected with FITC-labeled ODNs to NF-B for 24 hours (original magnification  400 at left;  100 at right). Transfection efficiency was
80% at 24 hours. C, Mediation by Src of H-2g–induced MNC migration in RA ST–SCID mouse chimeras in vivo. Human MNCs were transfected
with Src sense or antisense ODNs for 72 hours. After transfection, dye-tagged MNCs were administered IV into SCID mice engrafted with human
RA ST. While MNCs transfected with Src sense ODN migrated readily to RA ST in response to H-2g, Src antisense ODN–transfected MNCs did
not. Data represent the mean and SEM MNCs migrated in the entire tissue sections, as described in A. Thirty sections were evaluated from 5
separate mice for Src sense ODNs, and 39 sections were evaluated from 6 separate mice for Src antisense ODNs.   P  0.05. See Figure 1 for
other definitions.
692 AMIN ET AL
with sense ODNs, confirming that Src and PI 3-kinase
play an important role in H-2g–induced monocyte mi-
gration (Figure 1D).
H-2g recruits MNCs to human ST in an RA ST–
SCID mouse chimera. We used an RA ST–SCID mouse
chimera to examine H-2g–induced MNC migration in
vivo. ST grafts injected with H-2g showed a significant
increase in MNC migration compared with negative
control (PBS) (P  0.05). This increase was 8-fold higher
compared with PBS, suggesting that H-2g is a very potent
chemotactic stimulus for MNCs in vivo (Figure 2A).
Src antisense ODNs inhibit H-2g–induced MNC
recruitment into RA ST–SCID mouse chimeras. Trans-
fection with antisense ODNs resulted in significant
reduction of MNC migration in vivo compared with
sense ODN–treated controls in response to H-2g in an
Figure 3. A, Induction by H-2g of phosphorylation of human monocyte protein kinase CI/II (PKCI/II), Src, Akt, and IB. Monocytes were
stimulated with H-2g (200 nM) for 1, 5, 15, 30, or 45 minutes. H-2g induced a marked increase in PKCI/II, Src, Akt, and IB phosphorylation
in a time-dependent manner compared with unstimulated (NS) cells. Each blot represents 1 of 3 experiments using blood obtained from different
donors. B, Transient transfection of monocytes with PKC and Src sense and antisense ODNs. Monocytes were transfected with PKC or Src sense
and antisense ODNs for 48–72 hours before stimulation with H-2g for 15 minutes. Cell lysates were collected and Western blotting was performed.
PKC and Src antisense ODNs markedly reduced H-2g–induced phosphorylation compared with sense ODN–transfected monocytes. Blots were
reprobed for total PKC and Src to verify equal loading. C, Transient transfection of monocytes with Src sense and antisense ODNs for various time
periods. The transient transfection of monocytes with Src sense and antisense ODNs remained effective for 72 hours, as determined by decreased
H-2g–induced phospho-Src in monocytes transfected with Src antisense ODNs. D, Upstream location of H-2g–induced PKCI/II relative to Src,
Akt, and NF-B. H-2g–induced Src, Akt, and NF-B are the downstream targets of PKCI/II, since the inhibitor of PKCI/II decreased
H-2g–induced phosphorylation of Src, Akt, and NF-B. Src and PI 3-kinase/Akt pathways do not cross talk with each other, since the Src inhibitor,
PP2 529573, did not decrease H-2g–induced phosphorylation of Akt and vice versa. All inhibitors (10 M) were present in the medium during
monocyte stimulation with H-2g for 15 minutes. Each blot represents 1 of 2 experiments using blood obtained from different donors. PDTC 
pyrrolidine dithiocarbamate (see Figure 1 for other definitions).
H-2g AND MONONUCLEAR CELL RECRUITMENT 693
RA ST–SCID mouse chimera (Figure 2C). These results
show that targeting H-2g–mediated signaling pathways
may influence MNC migration to RA ST.
H-2g activates phosphorylation of PKCI/II,
Src, Akt, and IB in monocytes. H-2g induced phos-
phorylation of PKCI/II, Src, and Akt in monocytes
at 1 minute, with peak expression between 5 minutes and
30 minutes, which subsided at 45 minutes. IB phos-
phorylation, a measure of NF-B phosphorylation and
nuclear translocation, started at 5 minutes, with peak
expression between 15 minutes and 45 minutes
(Figure 3A).
H-2g–induced PKCI/II in monocytes is up-
stream of Src, Akt, and NF-B. Antisense ODNs of Src
and PKC decreased H-2g–induced phosphorylation of
Src and PKCI/II compared with that in sense ODN–
transfected monocytes, suggesting a knockdown of acti-
vated kinases by antisense ODN transfection (10) (Fig-
ure 3B). We found a marked decrease in H-2g–induced
phospho-Src in monocytes transfected with Src antisense
ODNs compared with monocytes transfected with Src
sense ODNs. The effect of transient transfection lasted
for 24–72 hours (Figure 3C).
H-2g activates a number of signaling pathways in
monocytes, including PKCI/II, Src, Akt, and NF-B.
We next studied the upstream and downstream targets
of these signaling intermediates. PKCI/II was up-
stream of Src, Akt, and NF-B, since an inhibitor of
PKCI/II (Ro-31-8425) abrogated the H-2g–induced
phosphorylation of all 3 molecules (Figure 3D).
DISCUSSION
We have demonstrated that H-2g induces
ICAM-1 and leukocyte–endothelial cell adhesion via
JAK-2/STAT, PI 3-kinase/Akt, and ERK-1/2 signaling
pathways (4). H-2g induces angiogenesis both directly
and by inducing basic fibroblast growth factor and
vascular endothelial growth factor (VEGF) via activat-
ing endothelial cell PI 3-kinase, JAK-2, and NF-B
signaling intermediates (3,5).
In this study, we demonstrate that H-2g is a novel
cytokine-like mediator of monocyte chemotaxis in vitro
and in vivo. We found that H-2g induced human mono-
cyte chemotaxis in a concentration-dependent manner in
vitro. H-2g–induced monocyte migration was signifi-
cantly decreased by inhibitors of Src and PI 3-kinase.
H-2g–induced monocyte migration was also inhibited by
antisense ODNs of Src and PI 3-kinase, confirming
chemical inhibitor data. This suggests that Src and PI
3-kinase are essential in H-2g–induced monocyte migra-
tion, but a G protein inhibitor, pertussis toxin, had no
effect.
To test the direct functional role of H-2g in
leukocyte migration in vivo and in relation to a disease,
we used a human RA ST–SCID mouse chimera. This
model has been used by us and other investigators to
examine the role of different cytokines in leukocyte
ingress (10,12). In the RA ST–SCID mouse chimera,
H-2g–induced MNC recruitment was significantly higher
compared with PBS. This suggests that H-2g may play a
critical role in chronic inflammatory diseases by medi-
ating leukocyte ingress.
We also used the RA ST–SCID mouse chimera
to elucidate the role of signaling molecules in MNC
homing by H-2g in an in vivo environment. Transfection
of MNCs with antisense ODN directed against Src
resulted in a significant decrease in H-2g–mediated cell
recruitment to engrafted RA ST compared with MNCs
transfected with Src sense ODN. These data suggest that
blockade of signaling intermediates important in H-2g–
mediated MNC recruitment may abrogate H-2g–
induced MNC ingress into inflammatory tissue.
PKC is composed of a family of 11 isoenzymes
that participate in T cell proliferation, differentiation,
and angiogenesis (13,14). PKC inhibitors were shown to
diminish arthritis in rat adjuvant-induced arthritis (13).
Because of those studies, we investigated whether H-2g
activated PKCI/II phosphorylation in monocytes.
H-2g induced phosphorylation of monocyte PKCI/II
isoforms in a time-dependent manner, with a maximum
response at 15 minutes.
Src kinases play an important role in RA by
participating in cell adhesion and leukocyte migration
(9,11,15). H-2g activates Src phosphorylation in mono-
cytes in a time-dependent manner. H-2g–induced Src
phosphorylation was inhibited by a PKCI/II inhibitor,
suggesting that PKCI/II is upstream of Src. Transfec-
tion of monocytes with PKC and Src antisense ODNs
markedly reduced PKCI/II and Src phosphorylation.
Similarly, we showed that ERK-1/2 MAPK antisense
ODN transfection significantly decreased ERK-1/2
phosphorylation in monocytes (10). The effect of tran-
sient transfection lasted for 72 hours, as we observed a
marked decrease in H-2g–induced phospho-Src in
monocytes transfected with antisense ODNs compared
with monocytes transfected with sense ODNs.
H-2g induces phosphorylation in monocytes of
the PI 3-kinase effector, Akt, in a time-dependent
manner. Inhibitors of both PKCI/II and PI 3-kinase
decrease Akt phosphorylation, suggesting that PKCI/
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II is upstream of PI 3-kinase, since Akt is a downstream
target of PI 3-kinase. Our data are concordant with
those of Gliki et al, who demonstrated that VEGF
induces PKC-dependent angiogenesis, and also that PI
3-kinase/Akt is a downstream target of PKC and PKC
in human umbilical vein ECs (14).
NF-B is an inducible transcription factor and is
a downstream target of PKC, PI 3-kinase, and JAK-2/
STAT signaling pathways (5,9,15). H-2g–induced NF-B
is a downstream target of PKC, since it is inhibited by a
PKC inhibitor. The NF-B/Rel transcription factors are
present in the cytosol in an inactive state complexed with
the inhibitory IB proteins. Activation occurs via phos-
phorylation of IB followed by degradation, resulting
in the release and nuclear translocation of active NF-B.
Phosphorylation of IB is essential and is an excellent
marker for release of active NF-B.
In conclusion, these data suggest that H-2g and
signaling intermediates induced by H-2g play an impor-
tant role in inflammation. H-2g may prove to be a
potential therapeutic target for the treatment of chronic
inflammatory diseases characterized by persistent leuko-
cyte recruitment, such as RA.
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